Are genetic polymorphisms of tumour necrosis factor alpha, interleukin-10, CD14 endotoxin receptor or manganese superoxide dismutase associated with alcoholic liver disease?
Authors:
- Helena Cortez-PintoHCHelena Cortez-Pinto
- Mariana MachadoMMMariana Machado
- Sara GonçalvesSGSara Gonçalves
- Pedro Marques-VidalPMPedro Marques-Vidal
- Ermelinda CamiloECErmelinda Camilo
- 1 October 2005
- journal article
- research article
- Published by Wolters Kluwer Health in European Journal of Gastroenterology & Hepatology
- Vol. 17 (10) , 1099-1104
Abstract
Background Four polymorphisms have been described associated with either increased risk for alcoholic liver disease (ALD) or more serious histological lesions: tumour necrosis factor alpha (TNF-α) G(−238)A, interleukin-10 (IL-10) C(−627)A, promoter of CD14 endotoxin receptor gene C(−159)T and manganese superoxide dismutase (MnSOD) C(−1183)T/valine → alanine. Methods We sought confirmatory evidence, through individual and simultaneous analysis of the four aforementioned polymorphisms, in 176 heavy drinkers: ALD (n=100) if histology-compatible or clinical evidence of hepatic decompensation; and no evidence of liver disease (NLD) (n=76) if normal liver tests on two occasions or normal liver histology (steatosis alone). Results Patients with ALD were older (53±10 vs. 48±10 years, P<0.05), with a similar sex distribution. TNF-α G(−238)A showed no difference in heterozygous GA-genotype prevalence (ALD, 9.0%/NLD, 7.9%). IL-10 C(−627)A showed no difference between groups, either homozygote AA (8.0% vs. 10.5%) or heterozygote CA (34.0% vs. 39.5%). CD14 promoter C(−159)T showed no difference between groups in T-allele frequency, either homozygote TT (27% vs. 21%) or heterozygote CT (49% vs. 50%). Alanine MnSOD allele carriers showed no difference between groups in either the heterozygote (55.0% vs. 49.3%) or homozygote (22% vs. 25%). No difference was observed in the probability of having simultaneously two, three or four of the implicated polymorphisms: respectively, 43%, 33% and 0% in ALD, and 43%, 24% and 5% in NLD (not significant). Conclusions No association was found between the previously implicated polymorphisms of TNF-α, IL-10, CD14 and MnSOD, either individually or simultaneously, and the presence of established ALD.Keywords
This publication has 30 references indexed in Scilit:
- Liver disease-related admissions in PortugalEuropean Journal of Gastroenterology & Hepatology, 2004
- Valine-alanine manganese superoxide dismutase polymorphism is not associated with alcohol-induced oxidative stress or liver fibrosisHepatology, 2002
- Interleukin 10 promoter region polymorphisms and susceptibility to advanced alcoholic liver diseaseGut, 2000
- Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitisHepatology, 1997
- Genetic polymorphism of cytochrome P4502E1 and risk of alcoholic liver disease in CaucasiansPharmacogenetics, 1995
- Polymorphism at the P450IIE1 Locus Is Not Associated with Alcoholic Liver Disease in Caucasian MenAlcohol, Clinical and Experimental Research, 1995
- The biochemistry of alcohol-induced fatty liverBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1994
- Plasma Tumor Necrosis Factor α Predicts Decreased Long‐Term Survival in Severe Alcoholic HepatitisAlcohol, Clinical and Experimental Research, 1990
- Excessive In Vitro Bacterial Lipopolysaccharide–Induced Production of Monokines in CirrhosisHepatology, 1990
- Alcohol and Liver Injury: dose‐related or permissive effect?British Journal of Addiction, 1989